Advanced Filters
noise

Benign Prostatic Hyperplasia Clinical Trials

A listing of Benign Prostatic Hyperplasia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 84 clinical trials
K Kazım Ceviz

Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy

Holmium Laser Enucleation of the Prostate (HoLEP) is an increasingly popular endoscopic minimally invasive surgical technique for the treatment of benign prostatic hyperplasia (BPH). In the literature, the long-term efficacy and low complication rates of HoLEP have been highlighted in many studies. However, in the early postoperative period, particularly within …

40 - 85 years of age Male Phase N/A
R Ruben Sauer, MD

Prostate Single Port & Laser Enucleation Comparison Trial

Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 80 ml. Minimally invasive approaches, such as robotic-assisted simple prostatectomy, have …

18 - 88 years of age Male Phase N/A
V Vladislav Petov

Safety and Efficacy of MILEP Versus Standard EEP

Endoscopic enucleation of the prostate (EEP) is a standard treatment for benign prostatic hyperplasia (BPH), with modifications such as MiLEP that utilizes smaller instruments. The reduced resectoscope diameter in MiLEP may help decrease rates of stress urinary incontinence (SUI) and urethral strictures. Objective: to compare the efficacy and safety of …

18 - 85 years of age Male Phase N/A
P Petar Bajic, MD

Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is a common condition affecting aging men, often leading to lower urinary tract symptoms (LUTS). While Minimally Invasive Surgical Therapies (MIST) procedures offer less invasive alternatives to traditional surgery, some patients experience symptom recurrence or require further intervention due to lack of adequate relief of obstruction. …

40 years of age Male Phase N/A
Y Yakup Kordan, MD, Professor

INTUPRO in the Treatment of Benign Prostatic Hyperplasia-Related Symptoms

The goal of this clinical trial is to determine whether INTUPRO can improve the quality of life in patients with Benign Prostate Hyperplasia (BPH). The main questions it aims to answer are: Can INTUPRO treatment lead to the removal of the Foley catheter? Can INTUPRO treatment improve urinary flow? Can …

45 years of age Male Phase N/A
B BARY DELONGCHAMPS Nicolas, Pr

Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction

It has been demonstrated that sexual activity was common in the majority of men over 50 years old and was an important component of overall quality of life (QoL). Ejaculatory dysfunction (EjD) is the most common side effect of surgical treatment of benign prostatic obstruction (BPO). It has been considered …

40 years of age Male Phase N/A
V Vincent Misraï, Dr

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)

Benign prostatic hyperplasia (BPH) is a very common pathology of the aging man with an incidence that rises from 40% in men aged 50 to 60 years to 90% in men over 80 years. Studies such as the MTOPS (the Medical Therapy of Prostatic Symptoms) study show that more than …

18 years of age Male Phase N/A
J Jill Moland

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.

50 years of age Male Phase N/A
P Pooja Talaty

Effects of TNF Blockade on Human BPH/LUTS

Specific Aim 1. To evaluate the efficacy of TNF antagonist action in BPH/LUTS Specific Aim 2. Define the consequences of TNF antagonist therapy on prostate tissue Specific Aim 3. Identify genetic predictors to stratify patients with differential response to TNF-antagonist therapy.

45 - 80 years of age Male Phase 2
G Gautier Müllhaupt, MD

Aquablation vs. Holmium Laser Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia in Medium to Large Size Prostates

Benign prostatic hyperplasia (BPH) is one of the most common diseases in men. As BPH progresses, surgical treatments often become necessary. Holmium enucleation of the prostate (HoLEP) is an established procedure in the surgical treatment of BPH, especially for medium to large prostates. The long learning curve, the length of …

45 years of age Male Phase N/A

Simplify language using AI